Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bengt Winblad

Showing results (451-460 of 538) with videos related to

Pageof 54
Sort By:
Neurobiology of Aging|August 6, 2017
CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patientsTobias Skillbäck, Louise Delsing, Jane Synnergren, et al.
Ebiomedicine|February 21, 2025
Blood N-glycomics reveals individuals at risk for cognitive decline and Alzheimer's diseaseRobin Ziyue Zhou, Stefan Gaunitz, Bjørn-Eivind Kirsebom, et al.
Brain : a Journal of Neurology|July 3, 2015
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementiaTobias Skillbäck, Bahman Y Farahmand, Christoffer Rosén, et al.
Neurochemistry International|April 24, 2012
Identification of two novel synaptic γ-secretase associated proteins that affect amyloid β-peptide levels without altering Notch processingSusanne Frykman, Yasuhiro Teranishi, Ji-Yeun Hur, et al.
Neurology|October 8, 2017
Thrombolysis in acute ischemic stroke in patients with dementia: A Swedish registry studyEva Zupanic, Mia von Euler, Ingemar Kåreholt, et al.
The Journal of Biological Chemistry|April 16, 2013
Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer diseaseZhi Tang, Erika Bereczki, Haiyan Zhang, et al.
Journal of Alzheimer'S Disease : JAD|August 17, 2013
Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's diseaseRon L H Handels, Weili Xu, Debora Rizzuto, et al.
Neurobiology of Aging|March 21, 2017
The biomarker-based diagnosis of Alzheimer's disease. 2-lessons from oncologyMarina Boccardi, Valentina Gallo, Yutaka Yasui, et al.
Nature Medicine|March 27, 2025
Blood-based biomarkers of Alzheimer's disease and incident dementia in the communityGiulia Grande, Martina Valletta, Debora Rizzuto, et al.
Neuroscience Letters|June 1, 2007
Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's diseaseAndrea Carmine Belin, Behnosh F Björk, Marie Westerlund, et al.
Pageof 54

Showing results (451-460 of 538) with videos related to

Sort By:
Pageof 54
Neurobiology of Aging|August 6, 2017
CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patientsTobias Skillbäck, Louise Delsing, Jane Synnergren, et al.
Ebiomedicine|February 21, 2025
Blood N-glycomics reveals individuals at risk for cognitive decline and Alzheimer's diseaseRobin Ziyue Zhou, Stefan Gaunitz, Bjørn-Eivind Kirsebom, et al.
Brain : a Journal of Neurology|July 3, 2015
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementiaTobias Skillbäck, Bahman Y Farahmand, Christoffer Rosén, et al.
Neurochemistry International|April 24, 2012
Identification of two novel synaptic γ-secretase associated proteins that affect amyloid β-peptide levels without altering Notch processingSusanne Frykman, Yasuhiro Teranishi, Ji-Yeun Hur, et al.
Neurology|October 8, 2017
Thrombolysis in acute ischemic stroke in patients with dementia: A Swedish registry studyEva Zupanic, Mia von Euler, Ingemar Kåreholt, et al.
The Journal of Biological Chemistry|April 16, 2013
Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer diseaseZhi Tang, Erika Bereczki, Haiyan Zhang, et al.
Journal of Alzheimer'S Disease : JAD|August 17, 2013
Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's diseaseRon L H Handels, Weili Xu, Debora Rizzuto, et al.
Neurobiology of Aging|March 21, 2017
The biomarker-based diagnosis of Alzheimer's disease. 2-lessons from oncologyMarina Boccardi, Valentina Gallo, Yutaka Yasui, et al.
Nature Medicine|March 27, 2025
Blood-based biomarkers of Alzheimer's disease and incident dementia in the communityGiulia Grande, Martina Valletta, Debora Rizzuto, et al.
Neuroscience Letters|June 1, 2007
Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's diseaseAndrea Carmine Belin, Behnosh F Björk, Marie Westerlund, et al.
Pageof 54